Serological cross-reactivity between Mycoplasma pulmonis and Mycoplasma arthriditis was investigated by enzyme-linked immunosorbent assay, immunoanalysis of electrophoretic blots, and protein A immunoprecipitation reactions. The results demonstrate that one-way cross-reactivity was present in both hyperimmunized and naturally infected rats and that the predominant cross-reactive antigens were M. pulmonis surface proteins. Distinct immunoblot patterns were demonstrated for M. pulmonis and M. arthriditis, allowing differentiation of the two species. The response to M. arthriditis antigens during natural infections differed greatly from that during hyperimmunization. Evidence suggested that nonprotein antigens were major determinants eliciting the antibody response to this mycoplasma.
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Mycoplasma pulmonis causes two of the most serious, spontaneous diseases of laboratory rats and mice. M. pulmonis is best known for its etiological role in murine respiratory mycoplasmosis which is a major disease problem in long-term rodent studies (7) . In addition to respiratory disease, this organism produces genital infections, resulting in reduced birth rates (4, 7, 9) . Cesarean derivation and barrier maintenance have been used as control measures for M. pulmonis infections, but in utero transmission (4) can negate these efforts. Thus, M. pulmonis infection is a serious threat to both the production and use of laboratory rats and mice. More insidious and less appreciated are the possible effects of inapparent M. pulmonis infection on physiological mechanisms, especially those of the immune system (7; J. R. Lindsey, M. K. Davidson , T. R. Schoeb, and G. H. Cassell, Proc. (IIT Conf. Toxicol. 6th, Raleigh, N.C., 1983, in press).
Recent surveys in Japan (22) , the United Kingdom (23) , and the United States (5, 8) indicate a continued wide prevalence of M. pulmonis in both conventional and barriermaintained ("specific pathogen-free") animals. Mycoplasma arthritidis, which is also capable of complicating research involving the use of laboratory rodents (Lindsey et al., Proc. CIIT Conf. Toxicol., in press), has been recently identified in commercially available, supposedly specific pathogen-free barrier-maintained rats and mice (11) . The prevalence of M. arthritidis infection in rodent colonies is unknown.
A one-way serological cross-reactivity between M. pulmonis and M. arthriditis in mice has been previously demonstrated in an enzyme-linked immunosorbent assay (ELISA) (15) . This cross-reactivity can be an advantage in screening rodent colonies for mycoplasmal disease if both the source and the nature of the cross-reactivity have been defined. Inapparent mycoplasmal infections could be detected, and the Mycoplasma species could be identified by utilizing this knowledge in ELISA and other sensitive immunological assays.
The goal of the present study was (16) .
Immunoreagents. Hyperimmune rabbit sera to M. ptulmonis and M. arthriditis were produced with organisms grown in mycoplasma broth (15) supplemented with rabbit serum. The organisms were harvested, washed with PBS by centrifugation, and suspended to 0.1 mg of protein per ml (18) in PBS. New Zealand white rabbits were immunized by previously described methods (3) .
Hyperimmune sera were produced in F344 rats (2 months of age) and CD-1 mice (6 weeks of age) by intravenous injection of 108 organisms suspended in 0.1 ml of mycoplasma broth supplemented with horse serum. All animals except those inoculated with M. arthriditis were challenged intranasally with an additional dose on day 21, and all animals were exsanguinated on day 28.
F344 rats were experimentally infected by intranasal inoculation of 108 CFU of M. piulmonis in 0.05 ml of mycoplasma broth supplemented with horse serum. The animals were sacrificed after 28 days. Pneumonia and otitis were present at the time of sacrifice.
Sera from F344 and LEW rats naturally infected with M. pulmonis or M. arthritidis were obtained from individual animals from isolator-and barrier-maintained colonies, respectively, which were known to have endemic mycoplasmal infections. Serum was collected from a LEW rat from which M. pulmonis was recovered from nasal passages and trachea. Serum was also collected from a LEW rat from which M. arthriditis was isolated from the uterus. The organisms were positively identified by glucose and arginine fermentation, hemadsorption, and immunofluorescence (1, 13, 14, 21) .
Adsorption of antisera. Hyperimmune rat anti-M. pulmonis and anti-M. arthriditis antisera were adsorbed with intact organisms by suspending a pellet containing 109 CFU in 1 ml of diluted antiserum (1:10 in PBS) and incubating the suspension for 30 min at room temperature. This was repeated twice, and the final supernatant was tested by ELISA.
ELISA. ELISA was performed as described before (16) To determine whether medium components were responsible for the cross-reaction observed in the ELISA, both sterile agamma horse serum and mycoplasma broth were used undiluted or diluted (1:10 and 1:100 in coating buffer) as ELISA antigens. Antisera were diluted 1:100 in PBSTA or in PBSTA containing 1% horse serum to determine whether addition of horse serum to the diluent could reduce potential reactions.
Enzyme and chemical treatments. Antigen-coated ELISA tubes, microtiter wells, or intact organisms were treated with trypsin (0.1 to 1 mg/ml) (Sigma Chemical Co.), pronase (0.1 to 1 mg/ml) (Calbiochem-Behring), and chymotrypsin ( (2 x 106 to 5 x 106 cpm/ml). RIP was performed by mixing 100 pL of radiolabeled antigens (5 x 105 cpm) and 5 pLI of normal, immune, or hyperimmune serum. This reaction mixture was incubated overnight (18 to 24 h) at 4°C. Sepharose-protein A immunosorbent (Pharmacia Fine Chemicals) was washed three times with RIP buffer, and 100 pL of a 10% suspension in RIP buffer was added to the reaction mixture. The contents of the tube were agitated and maintained at 4°C for 1 h. The resulting protein A-antibody-antigen complexes were washed four times with RIP buffer by centrifugation, and final pellets were solubilized in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer.
Electrophoresis. Washed organisms were suspended in water (2 to 5 mg of protein per ml) and solubilized by the addition of an equal volume of SDS-PAGE sample buffer containing 125 mM Tris, 20% glycerol, 4% SDS, and 10% 2-mercaptoethanol, pH 6.8. RIP samples were suspended in a 1:1 mixture of water and sample buffer. All samples were heated at 100°C for 2 min, cooled, and then layered on the stacking gel.
Slab gel electrophoresis was performed by the method of Laemmli (17) , using a 3% stacking layer (pH 6.8) and a 9% resolving gel (pH 8.8). Electrophoresis chemicals and reagents were obtained from Bio-Rad Laboratories. A Bio-Rad model 220 dual slab gel apparatus was used with a Buchler (Table 3 ). Antiserum to broth- inoculated control animals has been shown previously to be unreactive in the ELISA (10) .
To determine the nature of the cross-reactive antigens, the effect of enzyme and chemical treatments of antigen-coated tubes on ELISA values was investigated. Treatment of M. pulmonis antigen-coated (whole-cell lysate) solid-phase adsorbents with trypsin or pronase significantly reduced ELISA reactivity with both homologous and heterologous antisera (Table 4) . However, proteolytic treatment of M. arthritidis antigen (whole-cell lysate) did not affect reactivity with homologous antiserum. Treatment of either M. pulmonis or M. arthritidis lysate antigens bound to solid-phase adsorbents with periodate alone had no effect on ELISA reactivity, but periodate in combination with proteolytic treatment completely abolished the reactivity of M. pulmonis with both homologous and heterologous antisera (Table 4) . It should be noted that a shorter substrate color development time indicated that the homologous reaction was affected by the proteolytic treatments, with a maximum reduction of 40% of the control after chymotrypsin treatment. Combined treatment of M. arthritidis resulted in significantly reduced reactivity with homologous antisera.
By using [14Clpalmitic acid-labeled ELISA antigen preparations, the ability of enzyme treatments to release membrane fragments from the plastic surface was tested. After treatments witn trypsin (100 ,ug/ml of PBS for 1 h at 37°C) and pronase (0.1 mg/ml of PBS for 1 h at 37°C), 75 and 73% of the total counts remained, respectively. This indicated that although some losses of lipid material (presumably membrane fragments) occurred during the enzyme treatments, To determine what proportion of the cross-reactivity was due to proteolysis sensitive surface components, intact M. pulmonis organisms were treated with trypsin, chymotrypsin, or pronase and then used as the solid-phase antigen in the ELISA. Reactivity was reduced by treatments with all three enzymes (Table 5 ). (Fig. 1, lanes 2 and 3) . Antiserum to M. pulmonis did not recognize M. arthritidis antigens (Fig. 1, lane 1 (Fig. 1, lane 4) . Trypsin treatment of intact M. pulmonis removed these four crossreactive proteins (Fig. 1, lane 5) .
Both M. pulmonis and M. arthritidis used as antigens for immunoblotting were grown in dialyzed medium; thus, the only high-molecular-weight proteins in the medium were those from the agamma horse serum supplement. Immunoblot analysis of mycoplasma preparations with rabbit antihorse serum (Miles Laboratories), gave faint bands in the range of 20K to 66K (data not shown), indicating a minimal amount of contamination. Furthermore, anti-M. arthritidis antiserum recognized a 66K horse serum component (Fig. 1,  lane 6 ), but this was clearly different from the four M. pulmonis protein antigens recognized by the same serum (72K to 95K). Recognition of the same four M. pulmonis proteins by animals naturally infected with M. arthritidis gave further evidence that these were not likely to be horse serum contaminants (Fig. 2, lane 10) . Two of the four crossreactive protein bands were relatively weak, and often only three bands could be seen (Fig. 2, lane 10) . This response was always indicative of the quality of the radioactive probe (anti-rat IgG) and was not due to the lack of cross-reacting antibodies. Freshly radiolabeled probes, using the same antiserum, gave the four protein bands (Fig. 1, lane 4) .
Sera from rats either hyperimmunized, experimentally infected, or naturally infected with M. pulmonis recognized many similar M. pulmonis protein antigens (Fig. 2, lanes 2,  4, and 6 ). In contrast, there was a profound difference between the M. arthritidis antigens recognized by homologous hyperimmune serum and serum from animals naturally infected with M. arthritidis (Fig. 2, lanes 7 and 9) . Serum from hyperimmunized rats recognized many protein bands, but serum from naturally infected rats did not recognize M. arthritidis proteins, at least by this technique.
RIP. RIP of metabolically labeled M. pulmonis proteins, using homologous sera from rats, mice, and rabbits, indicat- 1 and 2) or hyperimmune rat anti-M. arthritidis (lanes 3 to 6), followed by radiolabeled anti-rat IgG (heavy and light chains). The protein bands were visualized by autoradiography.
ed that these animals species recognize similar protein determinants (Fig. 3, lanes 2, 4, and 6 ). Furthermore, precipitation with heterologous sera indicated that all three animal species recognized cross-reactive protein antigens anti-M. pulinonis; and lane 7, rabbit anti-M. airthritidis. The proteins were separated by SDS-PAGE, using a 109c resolving gel, which was then impregnated with 2,5-diphenyloxazole and dried; the proteins were visualized by autoradiography. (Fig. 3, lanes 3, 5, and 7) . Serum from rabbits hyperimmunized with M. ptlimonis recognized a greater number of M. plulmonis proteins (Fig. 3, lane 6 ) than did sera from rats and mice. Likewise, serum from rabbits immunized with M. arthritidis recognized a greater number of cross-reactive antigens (Fig. 3, lane 7) .
DISCUSSION
The results presented here confirm our earlier demonstration of one-way cross-reactivity between M. pilinonis and M. arthritidis in mice (16) and extend these observations to rats and rabbits. These cross-reactions were not due to medium contaminants as shown by: (i) metabolic labeling of cross-reactive antigens; (ii) confirmed by electrophoretic blot analysis (Fig. 1, lane 5) , which also indicated that the blot-detected cross-reactive proteins were localized on the membrane surface. This is not surprising since immunization of rabbits with intact M. pulmonis often produces a strong response to membrane proteins with little reactivity toward internal soluble proteins (unpublished data).
Electroblot analysis should not be considered a total analysis of cross-reactive proteins. Some antigenic determinants, such as those requiring secondary protein structure, are lost during sample preparation for SDS-PAGE. Likewise, the immunoprecipitation reactions are limited by the efficacy of the radiolabeling procedure since only those proteins in a state of flux within the mycoplasma during the labeling procedure will be detected. Despite these limitations, however, several cross-reactive proteins were identified, and the possibility that they were medium contaminants (20) was excluded by the present studies.
Preliminary evidence suggests that the degree of crossreactivity may be dependent upon the strain of M. pulmonis as well as culture conditions. The strain used in this study (UAB5782C), a natural isolate of low artificial passage, is the strain used in our ELISA screening program of rodent colonies (8 It is also important to consider that the animals used in the present studies had chronic low levels of M. arthritidis infection (11) , which might elicit an antibody response different from that of hyperimmunized or high-dose experimentally infected animals. In addition, the antigens were prepared from the M. arthritidis PG6 (ATCC 19611) strain rather than a low-passage isolate from naturally infected animals. The effects, if any, of strain or passage level on antigenicity have not been determined.
As in any immunological study, the quality of the antiserum is indicative of the immunological status of the host and is of utmost importance in determining the confidence one has in the study. It should be noted that the rats used in the present study were barrier-maintained specific pathogenfree animals which had been monitored extensively both serologically and culturally for rodent mycoplasmas over a 4-year period. Certainly, rats naturally infected with M. arthritidis recognized M. pulmonis protein antigens (Fig. 2,  lane 10 ), but those protein patterns differed from those recognized during natural M. pulmonis infections (Fig. 2,  lanes 5 and 6) . The differences are, in fact, striking, suggesting that these animals were not infected with both organisms.
It is noteworthy that the serum used in lanes 5 and 6 of Fig. 3 was from an animal culturally negative for M. pulmonis, although other cagemates were culturally positive. This response is typical for ELISA IgG-positive rats, culturally positive rats, or for ELISA IgG-positive rats housed with infected animals which were culturally negative. In fact, every ELISA IgG-positive animal exposed to M. pulmonis-infected animals had an identical blot pattern when screened by this technique. Likewise, every animal that was ELISA IgG positive and either culturally positive for M. arthritidis or exposed to M. arthritidis-infected animals gave the same blot pattern (four bands with M. pulmonis antigens and weak or no response with M. arthritidis antigens). It is apparent from these results that ELISA-positive sera can be screened to identify the infecting mycoplasma by the electroblot method. The use of ELISA as a highly effective method for screening rodent colonies for M. pulmonis infection (7, 11, 12, 16) together with immunoblotting for differentiation between M. arthritidis and M. pulmonis infection now make it possible to determine more accurately whether a particular colony of rodents is mycoplasma infected and which species is involved. This is particularly important in view of the fact that mycoplasmas are not always readily cultured from infected animals (8, 11, 12) .
